Pamicogrel
Pamicogrel is a cyclooxygenase inhibitor that was under development for its anti-platelet-aggregation effects.[1][2]
Names | |
---|---|
IUPAC name
Ethyl 2-[2-[4,5-bis(4-methoxyphenyl)-1,3-thiazol-2-yl]pyrrol-1-yl]acetate | |
Other names
KB 3022, Paminate | |
Identifiers | |
3D model (JSmol) |
|
ChemSpider | |
PubChem CID |
|
UNII | |
CompTox Dashboard (EPA) |
|
| |
| |
Properties | |
C25H24N2O4S | |
Molar mass | 448.54 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
Infobox references | |
References
- Light P (September 1999). "Pamicogrel (Kanebo)". IDrugs. 2 (9): 938–42. PMID 16121308.
- "Pamicogrel inhibits platelet aggregation". Inpharma Weekly. 1272 (1): 11. January 2001. doi:10.2165/00128413-200112720-00021. S2CID 195132149.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.